Switzerland For the Swiss Agency for Therapeutic Products (Swissmedic), one of the world’s leading regulatory authorities, 2023 was an important year. Not only did the agency gain recognition from the World Health Organisation (WHO), Swissmedic also saw a Good Manufacturing Practice (GMP) agreement between Switzerland and the US FDA come into…
India India’s chemical industry is of vital importance to several industries, including pharmaceuticals, and exported USD 30.18 billion worth of products in 2022-23. Chemexcil’s Raghuveer Kini discusses his industry’s key role in global supply chains, his association’s strategic goals and achievements, and the need for continued international collaboration. In essence,…
Europe Ahead of the much-discussed implementation of an EU-wide legislative framework on joint clinical assessments in 2025, Merck’s Nikola Vesic outlines the scope and aims of the reform and highlights some of the challenges in bridging the gap between theoretical vision and practical implementation.* In 2022, the European Union…
Europe Edward Mc Gettrick and Sharon Gorman of Pfizer, writing in the January 2023 edition of DIA’s Global Forum magazine, examine the scope and impact of the European Union’s new Regulation on Health Technology Assessment. In December 2021, the European Commission (EC) adopted the Regulation on Health Technology Assessment (EU HTA…
Europe Sparks, the Swiss Exchange’s newly launched small and medium sized enterprise (SME) trading venue, intends to make it easier for biotech SMEs to raise capital and strengthen their profile. The Swiss biotech sector has proven to be attractive for investors, with venture capital investments rising almost steadily over the past…
MEA In the February edition of DIA’s Global Forum magazine Sybil Nana Ama Ossei-Agyeman-Yeboah of the West African Health Organization, Jane H. Mashingia from the East African Community Medicines Regulatory Harmonization Programme, and the Bill & Melinda Gates Foundation’s David Mukanga examine the state of joint assessment procedures in the East…
APAC Drawing on the findings of a recent report launched under the Business Ethics for APEC SMEs Initiative, Thomas Cueni of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) outlines the benefits for small and medium-sized enterprises (SMEs) of adopting ethical practices. Cueni highlights some of the key trends that emerged from report, conducted…
APAC Writing in the September edition of DIA’s Global Forum magazine, Rosilawati Ahmad of Malaysia’s National Pharmaceutical Regulatory Agency; Tharnkamol Chanprapaph of the Thai FDA; and Samvel Azatyan, Valerio Reggi, and Prapassorn Thanaphollert of the World Health Organization highlight the progress towards regulatory harmonization in ASEAN and work between country-level regulatory…
Europe Writing in the August edition of DIA’s Global Forum, Sanofi R&D’s Thomas Kühler outlines the bumpy journey towards the full adoption of Health Technology Assessment (HTA) across Europe. More than three years ago, in January 2018, the European Commission published a draft Regulation on Health Technology Assessment for the EU.…
Switzerland Regarded as one of the world’s leading regulatory bodies, Swissmedic stands alongside its equivalents in Europe, Japan, Canada, and Australia in terms of the evaluation and approval of new drugs, notably COVID-19 vaccines. Although its approval times are increasing, raising doubts about Swissmedic’s continued place at the top table of…
Switzerland Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a specialty pharma player focused on the digestive system, has overseen a number of acquisitions and the growth of the company from 30 to 300 employees. Here, he shares his insights on why M&A may be a better strategy…
Singapore Mervyn Lim, Vice President, ResMed Asia, shares the company’s journey through COVID-19 in the region, how the company is building on their digitalisation experience, his view on how different stakeholders have to come together to improve reimbursement, and the huge opportunity in a market where 80 percent of patients with…
See our Cookie Privacy Policy Here